How to File a Patent in Switzerland: A Practical Guide to the IPI and EPO Routes

Filing a patent in Switzerland turns on a choice that catches out many foreign businesses before they reach any procedural detail: which route to take. Switzerland sits outside the EU and the EEA, so the regional shortcuts that work elsewhere do not all apply here. An EU instrument such as the Unitary Patent does not reach Switzerland, and a Swiss-bound application is its own decision. There are two principal paths, and they differ in a way that matters enormously: the national route through IPI today grants a patent without substantively examining whether the invention is new or inventive, whereas the European route through the EPO is fully examined. This guide walks through both, and explains the features peculiar to Switzerland that shape the decision. It is general information, not legal advice.

The two routes, and why the difference matters

The first route is a Swiss national patent obtained from IPI, the Swiss Federal Institute of Intellectual Property (the Institut Federal de la Propriete Intellectuelle, also known by its short form IGE/IPI). IPI examines a national application for formal requirements, for unity of invention, for sufficiency of disclosure, and for whether the subject matter falls within the categories excluded or excepted from patentability, but, distinctively, it does not examine novelty or inventive step. A Swiss national patent therefore grants on the strength of a compliant application rather than a search and substantive assessment, and its validity on novelty and inventive-step grounds is tested only if someone challenges it, typically in litigation. This is the single most important thing to understand about the Swiss national system, and we cover it in depth in our guide to the fact that Swiss national patents carry no substantive examination.

One caveat to flag at the outset: the Swiss Patents Act is being revised, in a reform IPI commonly refers to as "Patent law 2027". The standard national grant is still expected to issue without examining novelty or inventive step, but the revised regime is set to let applicants request a fuller examination that does cover novelty and inventive step, and to introduce a fee-based search on the state of the art. Because the timing and detail of these changes are version-specific, confirm the current procedure, whether an optional full-examination request is available, and how the prior-art search works with IPI or a local representative before you commit to a route.

The second route is a European patent granted by the European Patent Office (EPO) under the European Patent Convention, designating Switzerland. The EPO is not an EU body, and Switzerland is a long-standing EPC member, so this route is fully available. The EPO searches and substantively examines the application against the prior art, then grants a European patent. Because it is examined, an EP route patent generally arrives with a stronger presumption of validity than an unexamined national grant, at the cost of a longer and more involved process. Be careful not to conflate the EPC with the EU: the EU Unitary Patent does not extend to Switzerland, so a unitary effect chosen at the EPO will not cover the Swiss market, and Switzerland must be reached as a designated EPC state in the classic way. The wider landscape sits under the Swiss patents pillar.

One territory: Switzerland and Liechtenstein together

A feature unique to this market is that Switzerland and Liechtenstein form a single, unitary patent protection territory under a bilateral treaty. A Swiss national patent granted by IPI, and a European patent designating Switzerland, both extend to Liechtenstein. Importantly, a granted European patent takes effect for the combined Switzerland-Liechtenstein territory automatically on grant, with no separate national validation step (no translation or validation filing of the kind required in many other EPC states). You cannot obtain patent protection for one of the two countries without the other, and you do not file separately for Liechtenstein. For a business assessing its footprint, this means a single Swiss filing decision covers two states, which is worth bearing in mind when you weigh Switzerland against neighbouring markets.

The specification, the claims and the drawings

A Swiss patent application generally consists of a request to grant, a description of the invention full enough to enable a skilled person to carry it out, one or more claims defining the protection you seek, an abstract, and any drawings needed to understand the invention. The claims do the legal work, marking the boundary of what you can later enforce. Their drafting is where most of the value and most of the risk sit, and this matters even more under the national route: because IPI does not test novelty or inventive step before grant, a poorly drafted claim is not caught by an examiner and may simply prove worthless or invalid the first time it is litigated. The grant is not a verdict on whether the invention was new or inventive. Switzerland also applies a strict approach to novelty, so any public disclosure before your filing date (or priority date, if you claim priority) can undermine patentability. The defensive habit is simple: file before you disclose.

Filing language and the local-representative requirement

IPI conducts proceedings in one of the Swiss official languages (German, French or Italian), and applications are generally handled in one of these. It is often possible to file in another language and supply a translation within a set period, but you should not rely on that as a default; confirm the current rule and the applicable deadline with IPI or a local representative. Where translation is needed, treat its quality as a substantive issue rather than an administrative one, because a shift in the meaning of a claim term can narrow your protection. Separately, an applicant without a domicile or seat in Switzerland generally must appoint a representative with an address in Switzerland to act before IPI and receive correspondence. Build representation into your timeline and budget from the outset, and confirm the current requirement with IPI or local counsel, as the precise rule is version-specific and has been the subject of liberalisation.

Publication, grant, and keeping the patent in force

Swiss applications are generally published once a set period has elapsed after filing, which publishes the technical disclosure. On the national route, because there is no substantive examination of novelty, the path to grant is comparatively direct once formalities are satisfied; on the EPO route, grant follows search, examination and any office actions before the European patent takes effect for the Switzerland-Liechtenstein territory. Grant is not the end of the cost. Renewal (annuity) fees keep a granted patent in force and generally begin accruing from an early year measured from the filing date, payable even while an application is still pending and continuing for the life of the patent; missing one can cause the patent to lapse. The exact schedules, amounts, start year and any grace periods are version-specific. Official fees apply, confirm the current schedule with IPI or local counsel, and diarise renewals well ahead of each due date rather than relying on a single reminder.

The PCT and Paris priority routes

The national IPI filing and the EPO filing are not the only ways in. A single international application under the Patent Cooperation Treaty secures an international filing date recognised across the member states and buys time, through an international phase, before you commit to specific regions. You then enter the national or regional phase, and for Switzerland that typically means entering either the Swiss national phase before IPI or the European phase before the EPO. The national and regional-phase deadlines under the PCT are strict and forfeiting them is permanent, so confirm the applicable deadline before relying on it; for the wider mechanics see our overview of the PCT route. Whichever path you take, where your home country is a Paris Convention or WTO member you can claim priority from an earlier foreign application if you file within the priority period, which lets a first filing set the effective date for the Swiss or European filing that follows. The length of that period is set by the rules, so confirm it rather than assuming. One further Swiss-specific caution: the Swissness rules strictly control the use of terms such as Swiss, Swiss made and the Swiss cross in branding, with origin tests that differ by product category; they are a separate matter from patent protection, so do not assume a Swiss patent licenses any such marketing claim, and confirm the current thresholds and rules with counsel.

A note before you file

IPEnvoy is not a law firm and does not provide legal advice; this is general information. The Swiss system rewards early filing, careful claim drafting, attentive deadline management, and above all a deliberate choice between the national route through IPI and the examined European route through the EPO. The fact that, today, an IPI grant does not certify novelty makes the quality of your application more important here than in examining jurisdictions, not less, and the planned Patents Act revision may change the options on the national route. Before you file, confirm the current position with IPI's official website and a qualified local IP professional, who can pressure-test your route choice, your disclosure timing, and the wording of your claims against the facts of your invention.